Logo image of PHN.MI

PHARMANUTRA SPA (PHN.MI) Stock Overview

BIT:PHN - IT0005274094 - Common Stock

48.55 EUR
-0.1 (-0.21%)
Last: 8/29/2025, 5:29:46 PM

PHN.MI Key Statistics, Chart & Performance

Key Statistics
52 Week High61.2
52 Week Low45.2
Market Cap469.96M
Shares9.68M
Float3.31M
Yearly Dividend0.85
Dividend Yield2.06%
EPS(TTM)2.42
PE20.06
Fwd PE19.27
Earnings (Next)09-07 2025-09-07
IPO07-18 2017-07-18
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products


PHN.MI short term performance overview.The bars show the price performance of PHN.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10

PHN.MI long term performance overview.The bars show the price performance of PHN.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20 -25

The current stock price of PHN.MI is 48.55 EUR. In the past month the price increased by 5.66%. In the past year, price decreased by -10.26%.

PHARMANUTRA SPA / PHN Daily stock chart

PHN.MI Competitors/Peers

The largest stocks on the EU markets in the "Personal Care Products" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LOR.DE L'OREAL 31.21 212.19B
OR.PA L'OREAL 31.21 212.16B
UNVB.DE UNILEVER PLC 24.01 131.86B
UNA.AS UNILEVER PLC 23.99 131.76B
1ELX.MI ESTEE LAUDER COMPANIES-CL A 60.62 28.14B
BEI.DE BEIERSDORF AG 25.72 23.83B
COTY.PA COTY INC-CL A 19.33 3.20B
ITP.PA INTERPARFUMS SA 18.55 2.64B
ICOS.MI INTERCOS SPA 24.37 1.15B
ONTEX.BR ONTEX GROUP NV 54.25 536.10M
ENV.MI ENERVIT 16.48 73.34M
JBOG.PA JACQUES BOGART N/A 62.13M

About PHN.MI

Company Profile

PHN logo image Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa and currently employs 115 full-time employees. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

Company Info

PHARMANUTRA SPA

Via delle Lenze n. 216/B

Pisa PISA IT

Employees: 118

PHN Company Website

PHN Investor Relations

Phone: 390507846500

PHARMANUTRA SPA / PHN.MI FAQ

What is the stock price of PHARMANUTRA SPA today?

The current stock price of PHN.MI is 48.55 EUR. The price decreased by -0.21% in the last trading session.


What is the ticker symbol for PHARMANUTRA SPA stock?

The exchange symbol of PHARMANUTRA SPA is PHN and it is listed on the Euronext Milan exchange.


On which exchange is PHN.MI stock listed?

PHN.MI stock is listed on the Euronext Milan exchange.


What is the price forecast or stock price prediction for PHARMANUTRA SPA stock?

6 analysts have analysed PHN.MI and the average price target is 80.58 EUR. This implies a price increase of 65.97% is expected in the next year compared to the current price of 48.55. Check the PHARMANUTRA SPA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PHARMANUTRA SPA worth?

PHARMANUTRA SPA (PHN.MI) has a market capitalization of 469.96M EUR. This makes PHN.MI a Small Cap stock.


How many employees does PHARMANUTRA SPA have?

PHARMANUTRA SPA (PHN.MI) currently has 118 employees.


What are the support and resistance levels for PHARMANUTRA SPA (PHN.MI) stock?

PHARMANUTRA SPA (PHN.MI) has a support level at 48.12 and a resistance level at 48.56. Check the full technical report for a detailed analysis of PHN.MI support and resistance levels.


Is PHARMANUTRA SPA (PHN.MI) expected to grow?

The Revenue of PHARMANUTRA SPA (PHN.MI) is expected to grow by 14.01% in the next year. Check the estimates tab for more information on the PHN.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PHARMANUTRA SPA (PHN.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PHARMANUTRA SPA (PHN.MI) stock pay dividends?

PHARMANUTRA SPA (PHN.MI) has a dividend yield of 2.06%. The yearly dividend amount is currently 0.85. Check the full fundamental report for a detailed analysis of PHN.MI dividend history, reliability and sustainability.


When does PHARMANUTRA SPA (PHN.MI) report earnings?

PHARMANUTRA SPA (PHN.MI) will report earnings on 2025-09-07.


What is the Price/Earnings (PE) ratio of PHARMANUTRA SPA (PHN.MI)?

The PE ratio for PHARMANUTRA SPA (PHN.MI) is 20.06. This is based on the reported non-GAAP earnings per share of 2.42 and the current share price of 48.55 EUR. Check the full fundamental report for a full analysis of the valuation metrics for PHN.MI.


PHN.MI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to PHN.MI. When comparing the yearly performance of all stocks, PHN.MI is a bad performer in the overall market: 76.74% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PHN.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 8 / 10 to PHN.MI. Both the health and profitability get an excellent rating, making PHN.MI a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PHN.MI Financial Highlights

Over the last trailing twelve months PHN.MI reported a non-GAAP Earnings per Share(EPS) of 2.42. The EPS increased by 29.72% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.77%
ROA 18.91%
ROE 36.18%
Debt/Equity 0.3
Chartmill High Growth Momentum
EPS Q2Q%-8.63%
Sales Q2Q%11.2%
EPS 1Y (TTM)29.72%
Revenue 1Y (TTM)16.16%

PHN.MI Forecast & Estimates

6 analysts have analysed PHN.MI and the average price target is 80.58 EUR. This implies a price increase of 65.97% is expected in the next year compared to the current price of 48.55.

For the next year, analysts expect an EPS growth of 13.36% and a revenue growth 14.01% for PHN.MI


Analysts
Analysts83.33
Price Target80.58 (65.97%)
EPS Next Y13.36%
Revenue Next Year14.01%

PHN.MI Ownership

Ownership
Inst Owners15.44%
Ins Owners65.02%
Short Float %N/A
Short RatioN/A